{
    "id": "44233166",
    "text": "TGBA01AD (also known as FKB01MD) is a serotonin reuptake inhibitor, 5-HT1A and 5-HT1D receptor agonist, and 5-HT2 receptor antagonist which is under development by Fabre-Kramer for the treatment of major depressive disorder. Fabre-Kramer: FKB01MD It has been in phase II clinical trials since 2009, and as of January 2016, remains in this phase of development. ==See also== * List of investigational antidepressants ==References== Category:5-HT1A agonists Category:5-HT1D agonists Category:5-HT2 antagonists Category:Antidepressants Category:Drugs with undisclosed chemical structures Category:Serotonin reuptake inhibitors ",
    "title": "TGBA01AD"
}